MedTrace Logo

PINS Stimulator System to Treat Severe Anorexia Nervosa

NCT02263404 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2016-10-14

No results posted yet for this study

Summary

Anorexia Nervosa (AN) has the highest mortality of any psychiatric disorder and a paucity of effective treatments. AN becomes intractable in around 20%, resulting in huge individual and healthcare costs. The study will help patients with severe AN using DBS. Individuals with severe intractable AN will be eligible to take part in the study.

Conditions

  • Anorexia Nervosa

Interventions

DEVICE

Deep Brain Stimulation

DBS Implant Stimulation

Sponsors & Collaborators

  • Beijing Tiantan Hospital

    collaborator OTHER

  • Beijing Pins Medical Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Li Luming, PhD · Tsinghua University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2018-12-31
Completion
2018-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02263404 on ClinicalTrials.gov